CLINICAL_TRIALS
research
· 2016-06-15
Clinical Trial Update: Observation of Medical Treatments in MBC HER2-negative Patients
Summary
This is an update on an observational study of medical treatments for patients with metastatic breast cancer that is HER2-negative.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Consorzio Oncotech | Conditions: Metastatic Breast Cancer | Status: UNKNOWN